Barry E. Gidal

5.3k citations
108 papers · 2.9k · 1 hit paper · h-index 31

Impact in

Papers in

Barry E. Gidal

101 papers receiving 2.7k citations

Barry E. Gidal's Hit Papers

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects 2018 · 355 citations
3550+2+5Years since publication100200300

Peers

Barry E. Gidal
Comparison fields: 5 of 121
  • Psychiatry and Mental health 1.4k
  • Pediatrics, Perinatology and Child Health 965
  • Pharmacology 522
  • Cellular and Molecular Neuroscience 513
  • Toxicology 42
Replace Peter M. Edelbroek with:
Peter M. Edelbroek Netherlands
Kenneth W. Sommerville United States
Cecilie Johannessen Landmark Norway
Manuela Contin Italy
Paul Rolan Australia
Angela K. Birnbaum United States
Frank Vajda Australia
G. Gatti Italy
John A. Messenheimer United States
Alan R. Kugler United States
Barry E. Gidal relative to Peter M. Edelbroek Netherlands Peter M. Edelbroek's profile →
Citations per field
00.5×4.1×
Peter M. Edelbroek · 1×
Citations per year

Countries citing papers authored by Barry E. Gidal

Since Specialization
Citations

This map shows the geographic impact of Barry E. Gidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry E. Gidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry E. Gidal more than expected).

Fields of papers citing papers by Barry E. Gidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry E. Gidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry E. Gidal. The network helps show where Barry E. Gidal may publish in the future.

Co-authors

The 25 scholars most cited alongside Barry E. Gidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barry E. Gidal Line = papers co-authored together Barry E. Gidal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Hit paper breakdown →
2018355
2
Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression.
1999157
3 2018147
4 2000120
5 1998106
6 201893
7 200482
8 199881
9 200569
10 200366
11 200762
12 200060
13 202057
14 200655
15
New and emerging treatment options for neuropathic pain.
200652
16 201850
17 201848
18 199745
19 200341
20 201541

About Barry E. Gidal

Barry E. Gidal is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Cellular and Molecular Neuroscience, Pharmacology and Oncology, having authored 108 papers that have together received 2.9k indexed citations. Recurring topics across this work include Epilepsy research and treatment (67 papers), Pharmacological Effects and Toxicity Studies (40 papers), Neuroscience and Neuropharmacology Research (12 papers), Pharmaceutical studies and practices (9 papers), Drug Transport and Resistance Mechanisms (7 papers), Cannabis and Cannabinoid Research (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmaceutical Economics and Policy (4 papers). The work is most often cited by research in Psychiatry and Mental health (1.4k citations), Pediatrics, Perinatology and Child Health (965 citations), Pharmacology (522 citations), Cellular and Molecular Neuroscience (513 citations) and Toxicology (42 citations). Barry E. Gidal has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include Raj D. Sheth, Gilmour Morrison, Bola Tayo, Graham Blakey, Lesley Taylor, Bruce P. Hermann, Jacqueline A. French, Michael Seidenberg, Michael E. Pitterle and Austin Woodard. Their work appears in journals such as Epilepsia, Epilepsy & Behavior, Epiliepsy currents, Annals of Pharmacotherapy and Epilepsy Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact